Neovascularization in Tissue Engineering
A prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release o...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/1/4/1246 |
id |
doaj-46f062ebb33c486ba6cd65339a118dd3 |
---|---|
record_format |
Article |
spelling |
doaj-46f062ebb33c486ba6cd65339a118dd32020-11-24T23:59:55ZengMDPI AGCells2073-44092012-12-01141246126010.3390/cells1041246Neovascularization in Tissue EngineeringJennifer C.-Y. ChungDominique Shum-TimA prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis.http://www.mdpi.com/2073-4409/1/4/1246neovascularizationangiogenesistherapeutic angiogenesisendothelial progenitor cells |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jennifer C.-Y. Chung Dominique Shum-Tim |
spellingShingle |
Jennifer C.-Y. Chung Dominique Shum-Tim Neovascularization in Tissue Engineering Cells neovascularization angiogenesis therapeutic angiogenesis endothelial progenitor cells |
author_facet |
Jennifer C.-Y. Chung Dominique Shum-Tim |
author_sort |
Jennifer C.-Y. Chung |
title |
Neovascularization in Tissue Engineering |
title_short |
Neovascularization in Tissue Engineering |
title_full |
Neovascularization in Tissue Engineering |
title_fullStr |
Neovascularization in Tissue Engineering |
title_full_unstemmed |
Neovascularization in Tissue Engineering |
title_sort |
neovascularization in tissue engineering |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2012-12-01 |
description |
A prerequisite for successful tissue engineering is adequate vascularization that would allow tissue engineering constructs to survive and grow. Angiogenic growth factors, alone and in combination, have been used to achieve this, and gene therapy has been used as a tool to enable sustained release of these angiogenic proteins. Cell-based therapy using endothelial cells and their precursors presents an alternative approach to tackling this challenge. These studies have occurred on a background of advancements in scaffold design and assays for assessing neovascularization. Finally, several studies have already attempted to translate research in neovascularization to clinical use in the blossoming field of therapeutic angiogenesis. |
topic |
neovascularization angiogenesis therapeutic angiogenesis endothelial progenitor cells |
url |
http://www.mdpi.com/2073-4409/1/4/1246 |
work_keys_str_mv |
AT jennifercychung neovascularizationintissueengineering AT dominiqueshumtim neovascularizationintissueengineering |
_version_ |
1725445627538571264 |